TCHBF
Price
$277.00
Change
-$0.00 (-0.00%)
Updated
Oct 21 closing price
USAQ
Price
$0.18
Change
-$0.01 (-5.26%)
Updated
Dec 18 closing price
Ad is loading...

TCHBF vs USAQ

Header iconTCHBF vs USAQ Comparison
Open Charts TCHBF vs USAQBanner chart's image
Tecan AG
Price$277.00
Change-$0.00 (-0.00%)
Volume$5
CapitalizationN/A
QHSLab
Price$0.18
Change-$0.01 (-5.26%)
Volume$31K
CapitalizationN/A
TCHBF vs USAQ Comparison Chart
Loading...
TCHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TCHBF vs. USAQ commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCHBF is a Hold and USAQ is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (TCHBF: $277.00 vs. USAQ: $0.18)
Brand notoriety: TCHBF and USAQ are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: TCHBF: 62% vs. USAQ: 247%
Market capitalization -- TCHBF: $5.09B vs. USAQ: $698.66K
TCHBF [@Medical Specialties] is valued at $5.09B. USAQ’s [@Medical Specialties] market capitalization is $698.66K. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCHBF’s FA Score shows that 1 FA rating(s) are green whileUSAQ’s FA Score has 0 green FA rating(s).

  • TCHBF’s FA Score: 1 green, 4 red.
  • USAQ’s FA Score: 0 green, 5 red.
According to our system of comparison, USAQ is a better buy in the long-term than TCHBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCHBF’s TA Score shows that 0 TA indicator(s) are bullish while USAQ’s TA Score has 6 bullish TA indicator(s).

  • TCHBF’s TA Score: 0 bullish, 1 bearish.
  • USAQ’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, USAQ is a better buy in the short-term than TCHBF.

Price Growth

TCHBF (@Medical Specialties) experienced а 0.00% price change this week, while USAQ (@Medical Specialties) price change was -4.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.45%. For the same industry, the average monthly price growth was +1.34%, and the average quarterly price growth was -1.01%.

Industries' Descriptions

@Medical Specialties (-4.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCHBF($5.09B) has a higher market cap than USAQ($699K). USAQ YTD gains are higher at: 101.778 vs. TCHBF (-27.297). TCHBF has higher annual earnings (EBITDA): 211M vs. USAQ (-473.6K). TCHBF has more cash in the bank: 291M vs. USAQ (93.1K). USAQ has less debt than TCHBF: USAQ (1.63M) vs TCHBF (308M). TCHBF has higher revenues than USAQ: TCHBF (1.14B) vs USAQ (1.24M).
TCHBFUSAQTCHBF / USAQ
Capitalization5.09B699K728,040%
EBITDA211M-473.6K-44,553%
Gain YTD-27.297101.778-27%
P/E Ratio34.48N/A-
Revenue1.14B1.24M92,184%
Total Cash291M93.1K312,567%
Total Debt308M1.63M18,907%
FUNDAMENTALS RATINGS
TCHBF vs USAQ: Fundamental Ratings
TCHBF
USAQ
OUTLOOK RATING
1..100
4382
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
77100
PRICE GROWTH RATING
1..100
7835
P/E GROWTH RATING
1..100
74100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCHBF's Valuation (13) in the null industry is somewhat better than the same rating for USAQ (54). This means that TCHBF’s stock grew somewhat faster than USAQ’s over the last 12 months.

TCHBF's Profit vs Risk Rating (82) in the null industry is in the same range as USAQ (100). This means that TCHBF’s stock grew similarly to USAQ’s over the last 12 months.

TCHBF's SMR Rating (77) in the null industry is in the same range as USAQ (100). This means that TCHBF’s stock grew similarly to USAQ’s over the last 12 months.

USAQ's Price Growth Rating (35) in the null industry is somewhat better than the same rating for TCHBF (78). This means that USAQ’s stock grew somewhat faster than TCHBF’s over the last 12 months.

TCHBF's P/E Growth Rating (74) in the null industry is in the same range as USAQ (100). This means that TCHBF’s stock grew similarly to USAQ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TCHBFUSAQ
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
60%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 3 days ago
77%
View a ticker or compare two or three
Ad is loading...
TCHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
USAQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIISX30.791.05
+3.54%
Virtus International S/C R6
SDVSX15.94N/A
N/A
Sit Dividend Growth S
BLADX9.37-0.09
-0.95%
BlackRock Managed Income Investor A
FSCIX36.28-1.40
-3.72%
Fidelity Advisor Small Cap I
VPCCX33.31-3.03
-8.34%
Vanguard PRIMECAP Core Inv

TCHBF and

Correlation & Price change

A.I.dvisor tells us that TCHBF and SAFLY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TCHBF and SAFLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCHBF
1D Price
Change %
TCHBF100%
N/A
SAFLY - TCHBF
31%
Poorly correlated
N/A
LZAGY - TCHBF
27%
Poorly correlated
-2.25%
FDMDF - TCHBF
25%
Poorly correlated
N/A
LZAGF - TCHBF
24%
Poorly correlated
-0.93%
FSPKF - TCHBF
22%
Poorly correlated
N/A
More

USAQ and

Correlation & Price change

A.I.dvisor tells us that USAQ and XVIPF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that USAQ and XVIPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To USAQ
1D Price
Change %
USAQ100%
-2.47%
XVIPF - USAQ
23%
Poorly correlated
N/A
ADMT - USAQ
21%
Poorly correlated
-31.27%
WUXIF - USAQ
13%
Poorly correlated
N/A
TDSGF - USAQ
10%
Poorly correlated
-0.87%
TCHBF - USAQ
7%
Poorly correlated
N/A
More